Loading...
BioMark Diagnostics Inc.
BUX.CN•CNQ
HealthcareMedical - Diagnostics & Research
CA$0.33
CA$0.00(0.00%)
BioMark Diagnostics Inc. (BUX.CN) Company Profile & Overview
Explore BioMark Diagnostics Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
BioMark Diagnostics Inc. (BUX.CN) Company Profile & Overview
BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOMr. Rashid Ahmed Maula Bux B.Sc., MBA
Contact Information
Company Facts
IPO DateNov 3, 2014
CountryCA
Actively Trading